ASIC Corporations (Foreign Licensees and ADIs) Instrument 2026/121

The Australian Securities and Investments Commission (ASIC) has issued the Corporations (Foreign Licensees and ADIs) Instrument 2026/121. This legislative instrument, authorised by the Corporations Act 2001, clarifies regulations for foreign financial institutions operating in Australia.

ASIC Corporations Amendment Instrument 2026/123

The Australian Securities and Investments Commission (ASIC) has issued the Corporations Amendment Instrument 2026/123, amending the Corporations Act 2001. This instrument is authorised by the Treasury and is effective from March 26, 2026.

ASIC Corporations Amendment Instrument 2026/116

The Australian Securities and Investments Commission (ASIC) has issued the ASIC Corporations Amendment Instrument 2026/116, which amends the Corporations Act 2001. This instrument is now in force and administered by the Department of the Treasury.

ASIC Corporations Amendment Repeal Instrument 2026/181

The Australian Securities and Investments Commission (ASIC) has issued the ASIC Corporations (Amendment and Repeal) Instrument 2026/181. This instrument repeals a previous legislative instrument related to corporations, as authorised by the Corporations Act 2001.

AASB 107 Statement of Cash Flows August 2015 Scheduled Maintenance

The Australian Accounting Standards Board (AASB) has issued a scheduled maintenance update for AASB 107 Statement of Cash Flows, August 2015. This update is administered by the Department of the Treasury and authorized under the Corporations Act 2001.

ASIC Corporations Instrument 2026/90

The Australian Securities and Investments Commission (ASIC) has issued the ASIC Corporations Instrument 2026/90, effective March 26, 2026. This instrument is authorised under the Corporations Act 2001 and relates to exposure periods for corporations.

ASIC Corporations Instrument 2026/104 Approved for Buy-backs and Takeovers

The Australian Securities and Investments Commission (ASIC) has issued ASIC Corporations Instrument 2026/104, which approves certain foreign markets for the purposes of buy-backs and takeovers under the Corporations Act 2001. This instrument is administered by the Department of the Treasury.

ASIC Corporations (Debenture Prospectuses) Instrument 2026/91

The Australian Securities and Investments Commission (ASIC) has issued the Corporations (Debenture Prospectuses) Instrument 2026/91, which amends existing regulations concerning debenture prospectuses. This instrument is authorised under the Corporations Act 2001 and is effective from March 26, 2026.

ASIC Corporations Amendment Instrument 2026/159

The Australian Securities and Investments Commission (ASIC) has registered the Corporations Amendment Instrument 2026/159. This instrument amends the Corporations Act 2001, with the changes taking effect on March 26, 2026. The specific nature of the amendments is not detailed in the provided text.

NYSE Proposes Amendments to Rule 8000 and 9000 Series

The New York Stock Exchange (NYSE) has proposed amendments to its Rule 8000 and 9000 Series concerning Security-Based Swap Submissions. This filing initiates the public comment period for these proposed rule changes.

NYSE Arca Proposed Rule Change: Options Regulatory Fee Methodology

NYSE Arca has filed a proposed rule change with the SEC to amend its Options Regulatory Fee (ORF) methodology. The proposed change aims to align with other options exchanges by assessing ORF only for options transactions occurring on the Exchange and cleared in the Customer range at The Options Clearing Corporation. The Exchange intends to implement this new methodology by July 1, 2026.

OFAC Sanctions Action Notice

The Office of Foreign Assets Control (OFAC) has published a notice announcing the placement of one or more individuals on the Specially Designated Nationals and Blocked Persons List (SDN List). This action blocks all property and interests in property subject to U.S. jurisdiction belonging to these individuals, and prohibits U.S. persons from engaging in transactions with them.

USMCA Labor Mechanism Dispute Settlement Roster Application Invitation

The Office of the United States Trade Representative (USTR) is inviting applications for inclusion on the facility-specific rapid response labor mechanism dispute settlement roster under the USMCA. Eligible individuals, including U.S. citizens and nationals of other countries, are encouraged to apply by April 27, 2026.

National Eye Institute Announces Closed Meeting Notice

The National Institutes of Health has issued a notice announcing a closed meeting of the Board of Scientific Counselors, National Eye Institute. The meeting will be held virtually on April 6, 2026, to review and evaluate individual intramural programs, personnel qualifications, and investigator performance.

Agency Information Collection Activities; Water Request

The Bureau of Indian Affairs (BIA) is seeking to renew an existing information collection activity related to water requests without changes. This notice is part of the process required by the Paperwork Reduction Act of 1995, allowing for public comment on the collection.

Interior Department Proposes Renewing Youth Conservation Corps Forms

The Department of the Interior has published a notice proposing to renew existing information collection forms for the Youth Conservation Corps without changes. This action is part of the Department's compliance with the Paperwork Reduction Act and seeks public comment on the necessity and accuracy of the forms.

Agency Seeks Approval for Education Contracts Under Johnson-O'Malley Act

The Bureau of Indian Affairs is seeking approval from the Office of Management and Budget to renew an existing information collection related to education contracts under the Johnson-O'Malley Act. This notice is part of the standard Paperwork Reduction Act process.

BIS Agency Information Collection Activities; OMB Review

The Bureau of Industry and Security (BIS) is submitting an information collection request to OMB for review and approval. This notice announces an extension of the current collection, titled 'Miscellaneous Licensing and Reporting Responsibilities and Enforcement,' with no changes to the existing activities. The collection supports export licensing and enforcement activities under the EAR.

FDA Correction: Withdrawal of 72 ANDAs - Upsher-Smith Laboratories

The FDA issued a correction to a notice that incorrectly announced the withdrawal of approval for Upsher-Smith Laboratories' abbreviated new drug application (ANDA) 070631 for valproic acid capsules. The company had timely requested that the approval not be withdrawn, and this correction reinstates its validity.

PBGC Releases QDRO Practical Guide for Divorce Benefit Division

The Pension Benefit Guaranty Corporation (PBGC) has released a new guide titled 'Qualified Domestic Relations Orders: A Practical Guide to Dividing PBGC Benefits in Divorce.' This guide is designed to assist participants and alternate payees of PBGC-trusteed pension plans in understanding the process of dividing pension benefits during divorce proceedings.

AbilityOne Commission: Proposed Additions and Deletions to Procurement List

The AbilityOne Commission has published a notice proposing additions and deletions to its Procurement List. These changes involve adding a Base Operations & Maintenance Services requirement and deleting several types of webbing straps and combat identification kits. The notice is open for public comment until April 25, 2026.

AbilityOne Commission: Procurement List Additions and Deletions

The AbilityOne Commission has added specific products and services to its Procurement List, which are to be furnished by nonprofit agencies employing individuals who are blind or have severe disabilities. This action mandates procurement of these items by designated federal contracting activities.

ECB Speech: Europe Faces Turbulence, War Risks, Inflation, and Fragmentation

In a speech on March 26, 2026, ECB Vice-President Luis de Guindos discussed the significant economic turbulence facing Europe, including war risks, inflation, and fragmentation. He highlighted the resilience shown by the euro area economy despite these challenges, but warned of potential systemic stress from the war in the Middle East and geoeconomic fragmentation.

Order GRANTED: Defendant's Motion to Dismiss Lorielle Sloan's complaint

The Delaware Superior Court granted Delaware State University's motion to dismiss Lorielle Sloan's complaint. The court found that Sloan's amended complaint failed to sufficiently allege facts to establish claims for retaliation or harassment under applicable statutes, including the Delaware Whistleblowers' Protection Act.

Opinion and Order on Motions to Amend Complaint and Judgment

The Delaware Superior Court issued an Opinion and Order addressing motions to amend a third-party complaint and for judgment on the pleadings. The court granted in part and denied in part these motions, impacting the ongoing litigation concerning a fatal assault at a senior living facility.

FDA Complaint Posted

The FDA has posted a complaint related to its regulations, with the comment period closing on March 25, 2026. The document is available for review on Regs.gov.

FDA Complaint Posted

The FDA has posted a complaint on March 25, 2026, which was closed for comments. The complaint document is available for download from the agency's regulations.gov portal.

FDA Complaint Filed

The Food and Drug Administration (FDA) has filed a complaint related to tobacco products. The comment period for this filing has closed. No further details on the nature of the complaint or specific parties involved are available in the provided information.

Letter from U.S. Patent Office to FDA CDER

The FDA's Center for Drug Evaluation and Research (CDER) has posted a letter received from the U.S. Patent and Trademark Office. The document is dated March 25, 2026, and is available for review on Regulations.gov.

FDA Completeness Assessment Correspondence

The FDA has posted Completeness Assessment Correspondence related to drug applications. This notice provides information from the Center for Drug Evaluation and Research (CDER) regarding the completeness of submitted applications.

FDA Complaint Document

The FDA has posted a complaint document related to FDA-2026-H-2608. The document is available for review, though no specific details about its content are provided in the initial posting. This notice serves to inform the public and relevant parties of the complaint's availability.

FDA Variance Renewal Request from Shine On Floyd Band

The Food and Drug Administration (FDA) has received a variance renewal request from Shine On Floyd Band. The document is available for review on regulations.gov, though no specific details or content are provided within the listing itself.

FDA Complaint Document

The FDA has posted a complaint document, FDA-2026-H-2883-0001, on March 25, 2026. The document is available via a link to regulations.gov, though no content is directly viewable or downloadable from the initial posting.

FDA Complaint Document

The FDA has posted a complaint document related to its Center for Tobacco Products (CTP). The document is available for review on Regulations.gov, though no specific details of the complaint are provided in the notice.

USPTO Letter to FDA CDER

The U.S. Patent and Trademark Office (USPTO) sent a letter to the FDA's Center for Drug Evaluation and Research (CDER). The document was posted on March 25, 2024, via Regulations.gov. No specific details or content of the letter are available.

FDA CDER Receives Letter from U.S. Patent Office

The FDA's Center for Drug Evaluation and Research (CDER) has received a letter from the U.S. Patent and Trademark Office. The document is available for review on Regulations.gov, though no specific content is provided in the listing.

FDA CDER Letter from U.S. Patent and Trademark Office

The FDA has posted a letter from the U.S. Patent and Trademark Office to its Center for Drug Evaluation and Research (CDER). The document is dated March 25, 2026, and is available for review on Regs.gov.

USPTO Letter to FDA CDER

The U.S. Patent and Trademark Office (USPTO) has sent a letter to the FDA's Center for Drug Evaluation and Research (CDER). The document is a notification, and no specific regulatory action or compliance requirement is detailed within the available information.

Patent Office Letter to FDA CDER

The FDA has posted a letter from the U.S. Patent and Trademark Office addressed to the FDA's Center for Drug Evaluation and Research (CDER). The document is available for review on Regulations.gov.

USPTO Letter to FDA CDER

The U.S. Patent and Trademark Office (USPTO) sent a letter to the FDA's Center for Drug Evaluation and Research (CDER). The document was posted on March 25, 2025, via Regs.gov. No content is available for viewing or download, only metadata about the letter.

USPTO Letter to FDA CDER

The U.S. Patent and Trademark Office (USPTO) has sent a letter to the FDA's Center for Drug Evaluation and Research (CDER). The document is available on Regs.gov, but no content or specific details of the letter's subject matter are provided.

Letter from U.S. Patent Office to FDA CDER

The FDA has posted a letter received from the U.S. Patent and Trademark Office addressed to the FDA's Center for Drug Evaluation and Research (CDER). The document is available for review on Regulations.gov.

FDA Complaint Filed and Closed for Comments

The FDA has filed a complaint related to tobacco products, with the comment period now closed. The specific details of the complaint and the affected parties are not available in the provided document.

Letter from USPTO to FDA CDER

The U.S. Patent and Trademark Office (USPTO) has sent a letter to the FDA's Center for Drug Evaluation and Research (CDER). The document is available for review on Regulations.gov, though no content is directly viewable within the portal.

FDA Complaint Filed

The FDA has posted a complaint filed on March 25, 2026. The complaint was authored by CTP and is now closed for comments. No documents are available for viewing or download.

White Coat Captioning LLC et al v. Twitter Inc. - Contract Dispute

A new civil case, White Coat Captioning LLC et al v. Twitter Inc., was filed on April 4, 2023, in the U.S. District Court for the Northern District of California. The case involves a contract dispute and has a last filing date of January 28, 2026.

SFC Freezes $219 Million in Assets of Suspected KNT Share Manipulators

The Securities and Futures Commission (SFC) of Hong Kong has obtained a court order to freeze assets up to $219 million belonging to four individuals suspected of manipulating KNT shares. This action is part of a broader enforcement effort, including parallel criminal proceedings against three of the suspects.

AG Wilson Challenges DEI Quotas for Racial Discrimination

Attorney General Alan Wilson, joined by 17 other states, filed an amicus brief supporting a challenge to the New Jersey State Bar Association's DEI quotas for its leadership board. The states argue that these quotas constitute unlawful racial discrimination, violating the First Amendment.

NRCS Hydric Soils Database Selection Criteria Update

The Natural Resources Conservation Service (NRCS) is announcing changes to the selection criteria for hydric soils used in the National Soil Information System (NASIS) Database. These updates, developed by the National Technical Committee for Hydric Soils (NTCHS), will incorporate subaqueous soils into the hydric soils list, reflecting updated mapping and knowledge.

NRCS Rescinds Environmental Impact Statement Notice for Wood River Watershed

The Natural Resources Conservation Service (NRCS) is rescinding its Notice of Intent to prepare an Environmental Impact Statement (EIS) for the Wood River Watershed project in Nebraska. The project has been terminated due to exceeding statutory acreage limits, making the EIS unnecessary.